Frank Tavassol, Oliver F Starke, Horst Kokemüller, Gerd Wegener, Corinna C M Müller-Tavassol, Nils-Claudius Gellrich, André Eckardt
{"title":"口腔癌患者热休克蛋白70 (HSP70)的预后意义。","authors":"Frank Tavassol, Oliver F Starke, Horst Kokemüller, Gerd Wegener, Corinna C M Müller-Tavassol, Nils-Claudius Gellrich, André Eckardt","doi":"10.1186/1758-3284-3-10","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oral squamous cell carcinoma (OSCC) is characterized by an aggressive growth pattern, local invasiveness, and spread to cervical lymph nodes. Overall survival rates have not improved, primarily due to locoregional tumor recurrences and distant metastasis. To date, no trustworthy or clinically applicable marker of tumor aggressiveness has been identified for OSCC. Heat shock proteins (HSPs) play a role in tumor antigenicity. This study aimed to investigate the expression and prognostic significance of highly stress-inducible HSP70 in OSCC.</p><p><strong>Methods: </strong>Immunohistochemical staining for HSP70 was performed on surgical specimens obtained from 61 patients with OSCC. Light microscopy and analysis 3.1® (Soft Imaging System, Münster, Germany), an image processing and analysis program, were used for evaluating HSP70 expression. The tumor region was defined as the region of interest (ROI) and HSP70-positive staining was analyzed.</p><p><strong>Results: </strong>Immunoreactivity for HSP70 was positive in tumor cells of 38 of all patients (63.3%). Positive immunoreactivity of tumor cells could be detected in 17 of 28 patients with T2 tumors (60.7%) Prognostic significance of HSP70 expression in tumor cells was detected in patients with T2 tumors (p = 0.009).</p><p><strong>Conclusions: </strong>The survival of patients suffering from T2 tumors with positive HSP70 expression was 8 times higher than that for patients with negative HSP70 expression, suggesting that T1-T2 tumors of OSCC with low expression of HSP70 require more radical treatment.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"3 ","pages":"10"},"PeriodicalIF":0.0000,"publicationDate":"2011-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-10","citationCount":"32","resultStr":"{\"title\":\"Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer.\",\"authors\":\"Frank Tavassol, Oliver F Starke, Horst Kokemüller, Gerd Wegener, Corinna C M Müller-Tavassol, Nils-Claudius Gellrich, André Eckardt\",\"doi\":\"10.1186/1758-3284-3-10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Oral squamous cell carcinoma (OSCC) is characterized by an aggressive growth pattern, local invasiveness, and spread to cervical lymph nodes. Overall survival rates have not improved, primarily due to locoregional tumor recurrences and distant metastasis. To date, no trustworthy or clinically applicable marker of tumor aggressiveness has been identified for OSCC. Heat shock proteins (HSPs) play a role in tumor antigenicity. This study aimed to investigate the expression and prognostic significance of highly stress-inducible HSP70 in OSCC.</p><p><strong>Methods: </strong>Immunohistochemical staining for HSP70 was performed on surgical specimens obtained from 61 patients with OSCC. Light microscopy and analysis 3.1® (Soft Imaging System, Münster, Germany), an image processing and analysis program, were used for evaluating HSP70 expression. The tumor region was defined as the region of interest (ROI) and HSP70-positive staining was analyzed.</p><p><strong>Results: </strong>Immunoreactivity for HSP70 was positive in tumor cells of 38 of all patients (63.3%). Positive immunoreactivity of tumor cells could be detected in 17 of 28 patients with T2 tumors (60.7%) Prognostic significance of HSP70 expression in tumor cells was detected in patients with T2 tumors (p = 0.009).</p><p><strong>Conclusions: </strong>The survival of patients suffering from T2 tumors with positive HSP70 expression was 8 times higher than that for patients with negative HSP70 expression, suggesting that T1-T2 tumors of OSCC with low expression of HSP70 require more radical treatment.</p>\",\"PeriodicalId\":49195,\"journal\":{\"name\":\"Head and Neck Optical Diagnostics Society\",\"volume\":\"3 \",\"pages\":\"10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-02-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/1758-3284-3-10\",\"citationCount\":\"32\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Head and Neck Optical Diagnostics Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/1758-3284-3-10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck Optical Diagnostics Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1758-3284-3-10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32
摘要
背景:口腔鳞状细胞癌(OSCC)的特点是侵袭性生长模式,局部侵袭性,并扩散到颈部淋巴结。总体生存率没有提高,主要是由于局部肿瘤复发和远处转移。到目前为止,还没有可靠的或临床适用的肿瘤侵袭性标志物被确定为OSCC。热休克蛋白(HSPs)在肿瘤抗原性中起重要作用。本研究旨在探讨高应激诱导的HSP70在OSCC中的表达及其预后意义。方法:对61例OSCC手术标本进行HSP70免疫组化染色。使用光学显微镜和分析3.1®(Soft Imaging System, m nster, Germany),一种图像处理和分析程序来评估HSP70的表达。将肿瘤区域定义为感兴趣区域(ROI),分析hsp70阳性染色。结果:38例患者肿瘤细胞HSP70阳性(63.3%)。28例T2肿瘤患者中有17例肿瘤细胞免疫反应性阳性(60.7%)。T2肿瘤患者肿瘤细胞中HSP70的表达具有预后意义(p = 0.009)。结论:HSP70表达阳性的T2肿瘤患者的生存率是HSP70表达阴性患者的8倍,提示HSP70低表达的OSCC T1-T2肿瘤需要更根治性的治疗。
Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer.
Background: Oral squamous cell carcinoma (OSCC) is characterized by an aggressive growth pattern, local invasiveness, and spread to cervical lymph nodes. Overall survival rates have not improved, primarily due to locoregional tumor recurrences and distant metastasis. To date, no trustworthy or clinically applicable marker of tumor aggressiveness has been identified for OSCC. Heat shock proteins (HSPs) play a role in tumor antigenicity. This study aimed to investigate the expression and prognostic significance of highly stress-inducible HSP70 in OSCC.
Methods: Immunohistochemical staining for HSP70 was performed on surgical specimens obtained from 61 patients with OSCC. Light microscopy and analysis 3.1® (Soft Imaging System, Münster, Germany), an image processing and analysis program, were used for evaluating HSP70 expression. The tumor region was defined as the region of interest (ROI) and HSP70-positive staining was analyzed.
Results: Immunoreactivity for HSP70 was positive in tumor cells of 38 of all patients (63.3%). Positive immunoreactivity of tumor cells could be detected in 17 of 28 patients with T2 tumors (60.7%) Prognostic significance of HSP70 expression in tumor cells was detected in patients with T2 tumors (p = 0.009).
Conclusions: The survival of patients suffering from T2 tumors with positive HSP70 expression was 8 times higher than that for patients with negative HSP70 expression, suggesting that T1-T2 tumors of OSCC with low expression of HSP70 require more radical treatment.